Alere intends to offer $450M of senior notes due 2018

Alere Inc. (NYSE: ALR) (the "Company") announced today that it intends to offer $450 million of senior notes due 2018 through a private placement, subject to market and other conditions.  The Company intends to use the net proceeds from the offering to finance its announced cash tender offer to repurchase any and all of its outstanding $250.0 million aggregate principal amount of 7.875% Senior Notes due 2016 (the "2016 Notes"), to repay outstanding revolving borrowings in the aggregate principal amount of approximately $97.5 million under its credit agreement and for working capital and other general corporate purposes, including the financing of potential acquisitions or investments, stock repurchases and capital expenditures. 

The Company may also use a portion of the net proceeds to pay all or a portion of any post-closing payment, earn-out payment or other form of deferred or contingent consideration for previously completed acquisitions.

Source:

Alere Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Alere Inc.. (2019, June 19). Alere intends to offer $450M of senior notes due 2018. News-Medical. Retrieved on January 27, 2021 from https://www.news-medical.net/news/20121128/Alere-intends-to-offer-24450M-of-senior-notes-due-2018.aspx.

  • MLA

    Alere Inc.. "Alere intends to offer $450M of senior notes due 2018". News-Medical. 27 January 2021. <https://www.news-medical.net/news/20121128/Alere-intends-to-offer-24450M-of-senior-notes-due-2018.aspx>.

  • Chicago

    Alere Inc.. "Alere intends to offer $450M of senior notes due 2018". News-Medical. https://www.news-medical.net/news/20121128/Alere-intends-to-offer-24450M-of-senior-notes-due-2018.aspx. (accessed January 27, 2021).

  • Harvard

    Alere Inc.. 2019. Alere intends to offer $450M of senior notes due 2018. News-Medical, viewed 27 January 2021, https://www.news-medical.net/news/20121128/Alere-intends-to-offer-24450M-of-senior-notes-due-2018.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Alere i RSV test receives FDA CLIA waiver for detection of RSV infection in children, adults